MetaTrader
  • Märkte
  • Charts & Ideen
  • Algo
  • Nachrichten
  • Store
  • Broker
  • Herunterladen
  • Wirtschaftskalender
  • Handelssignale
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Aligos Therapeutics, Inc. Common Stock

ALGS

#3397
Aligos Therapeutics, Inc. Common Stock
7.0300
+1.30%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
7.0300
7.0300
Jahresspanne
5.8200
13.6892
Tagesänderung
+1.30%
Monatliche Änderung
-19.10%
6 month change
-28.19%
Jahresänderung
-28.19%
Vorheriger Schlusskurs
6.9400
Open
7.0300
Bid
Ask
Low
7.0300
High
7.0300
Volumen
2
  1. Märkte
  2. Aktien
  3. Gesundheitswesen
  4. ALGS
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Nachrichten

Investing Investing
ALGS
2026.01.23
Aligos Therapeutics mantém recomendação de compra da H.C. Wainwright com avanço do pevifoscorvir
Investing Investing
ALGS
2026.01.23
Aligos Therapeutics stock maintains Buy rating at H.C. Wainwright on pevifoscorvir progress
Investing Investing
ALGS
2026.01.21
Ações da Aligos Therapeutics sobem com avanço do estudo de Fase 2 para HBV
Investing Investing
ALGS
2026.01.21
Aligos Therapeutics stock rises on Phase 2 HBV study progress
Investing Investing
ALGS
2026.01.21
Aligos relata progresso em estudo de medicamento para hepatite B de Fase 2
Investing Investing
ALGS
2026.01.21
Aligos reports progress on Phase 2 hepatitis B drug study
Investing Investing
ALGS
2026.01.13
Aligos Therapeutics nomeia James Hassard como diretor comercial
Investing Investing
ALGS
2026.01.13
Aligos therapeutics appoints James Hassard as chief commercial officer
Investing Investing
GILD MDGL ALGS
2026.01.07
Ações da Aligos Therapeutics recebem classificação de Compra pela UBS
Investing Investing
GILD MDGL ALGS
2026.01.07
Aligos Therapeutics stock initiated with Buy rating at UBS on liver disease pipeline
Investing Investing
ALGS
2025.12.11
Aligos relata efeito sinérgico de perda de peso com agonista THR-β
Investing Investing
ALGS
2025.12.11
Aligos reports synergistic weight loss effect with THR-β agonist

Märkte

  • Aktien
  • Währungen
  • Kryptowährungen
  • Metalle
  • Rohstoffe

Charts & Ideen

  • Handelsideen
  • Aufbildungsideen
  • Charts

MQL5 Community

  • Market
  • Signale
  • Forum
  • Artikel
  • CodeBase

Nachrichten

  • Aktien
  • Währungen
  • Kryptowährungen
  • Metalle
  • Rohstoffe

Broker

  • Alle Broker
  • Forex
  • Aktien
  • Metalle
MetaTrader 5
MQL5 Channels
Economic Calendar
Haftungsausschluss und Risikohinweis Nutzungsbedingungen Kontakt Rechtliche Hinweise
Copyright 2000-2026, MetaQuotes Ltd